This company listing is no longer active
Peijia Medical Future Growth
Future criteria checks 2/6
Peijia Medical is forecast to grow earnings and revenue by 61.5% and 29% per annum respectively. EPS is expected to grow by 61.3% per annum. Return on equity is forecast to be -2.9% in 3 years.
Key information
61.5%
Earnings growth rate
61.3%
EPS growth rate
| Medical Equipment earnings growth | 40.3% |
| Revenue growth rate | 29.0% |
| Future return on equity | -2.9% |
| Analyst coverage | Low |
| Last updated | 11 Sep 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,021 | -30 | -28 | N/A | 4 |
| 12/31/2025 | 814 | -102 | -131 | N/A | 4 |
| 12/31/2024 | 622 | -176 | -169 | N/A | 4 |
| 6/30/2024 | 517 | -252 | N/A | N/A | N/A |
| 3/31/2024 | 479 | -322 | N/A | N/A | N/A |
| 12/31/2023 | 441 | -393 | -900 | -583 | N/A |
| 9/30/2023 | 399 | -460 | -921 | -609 | N/A |
| 6/30/2023 | 357 | -528 | -942 | -635 | N/A |
| 3/31/2023 | 304 | -468 | -760 | -506 | N/A |
| 12/31/2022 | 251 | -408 | -579 | -376 | N/A |
| 9/30/2022 | 227 | -449 | -684 | -441 | N/A |
| 6/30/2022 | 204 | -491 | -790 | -506 | N/A |
| 3/31/2022 | 170 | -533 | -710 | -471 | N/A |
| 12/31/2021 | 137 | -574 | -629 | -436 | N/A |
| 9/30/2021 | 106 | -515 | -446 | -327 | N/A |
| 6/30/2021 | 76 | -455 | -262 | -217 | N/A |
| 3/31/2021 | 57 | -1,262 | -235 | -199 | N/A |
| 12/31/2020 | 39 | -2,069 | -207 | -181 | N/A |
| 9/30/2020 | 33 | -2,128 | -203 | -180 | N/A |
| 6/30/2020 | 28 | -2,187 | -200 | -179 | N/A |
| 3/31/2020 | 23 | -1,360 | -158 | -141 | N/A |
| 12/31/2019 | 19 | -532 | -116 | -103 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 9996 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 9996 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 9996 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 9996's revenue (29% per year) is forecast to grow faster than the Hong Kong market (7.3% per year).
High Growth Revenue: 9996's revenue (29% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 9996 is forecast to be unprofitable in 3 years.